Cost-effectiveness Analysis of Hiv/aids Test and Treat Strategy Vs. Current Trea
43,85 €
However, the cost-effectiveness studies related to "test and treat" strategy did not consider the possibility of increased drug resistance due to poor adherence, which is not rare in developing countries.
Jetzt bei Ebay:
